ETF Managers Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$542K Buy
+88,960
New +$482K 0.02% 432
2022
Q4
Sell
-80,512
Closed -$316K 550
2022
Q3
$316K Buy
80,512
+6,076
+8% +$30.5K 0.01% 547
2022
Q2
$377K Buy
74,436
+19,846
+36% +$103K 0.01% 562
2022
Q1
$353K Sell
54,590
-4,280
-7% -$28.4K 0.01% 520
2021
Q4
$462K Buy
+58,870
New +$555K 0.01% 526

Other funds holding CLBT

ETF Managers Group's CLBT Position: Q1 2023 in Review

ETF Managers Group opened a new position in Cellebrite (CLBT) in Q1 2023: 88,960 shares worth $542K. The stake represents 0.02% of the portfolio and ranks #432 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in CLBT as recently as Q3 2022.

ETF Managers Group first reported a position in CLBT in Q4 2021 and has held it in 5 quarters since. 59 funds tracked by Wall St. Rank hold CLBT as of Q1 2023.

  • ETF Managers Group held 88,960 shares of Cellebrite worth $542K as of Q1 2023.
  • Cellebrite was a new ETF Managers Group position in Q1 2023.
  • Cellebrite made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #432 holding.
  • ETF Managers Group first reported a position in Cellebrite in Q4 2021 and has held it in 5 quarters since.
  • 59 funds tracked by Wall St. Rank held Cellebrite as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.